Brightseed

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Brightseed sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 3 currently recruiting upper quartile by trial count

Brightseed: 3 sponsored US clinical trials, 3 recruiting.

Brightseed sponsors 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Intestinal Permeability, with 1 trials.

Upper-quartile sponsor footprint

Brightseed sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING NA

Dietary Supplementation on Fat Oxidation

NCT06548048
RECRUITING NA

Dietary Supplementation on Body Fat Composition

NCT06296251
RECRUITING NA

Dietary Supplementation on Gastrointestinal Barrier Function

NCT06262880

Therapeutic Areas

Intestinal Permeability 1
PreDiabetes 1
Overweight 1
Obesity 1
Dyslipidemias 1

What is open in the Brightseed pipeline

3 recruiting of 3 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Intestinal Permeability (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Brightseed: open-pipeline peers nationwide

Peers matched on 3 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Brightseed sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%50%100%150% Total trials Recruiting share Brightseed10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Brightseed sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Brightseed sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Brightseed page

3 registered trials is a research-attention snapshot, not an endorsement of Brightseed or any single study.

  • 3 of Brightseed's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Intestinal Permeability is the condition Brightseed studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Intestinal Permeability trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Brightseed pipeline card: 3 registered trials from official public datasets.Report a data error.